Synapse - Zhigang Zhang

Search Within

Zhigang Zhang

Results (71)

SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes

Journal Article

Brennan, V. S.; Burleson, S.; Kostrzewa, C.; Godoy Scripes, P.; Subashi, E.; Zhang, Z.; Tyagi, N.; Zelefsky, M. J.
Radiotherapy and Oncology (2023)

Fulltext@MSK | Save

A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma

Journal Article

Rimner, A.; Adusumilli, P. S.; Offin, M. D.; Solomon, S. B.; Ziv, E.; Hayes, S. A.; Ginsberg, M. S.; Sauter, J. L.; Gelblum, D. Y.; Shepherd, A. F.; more...
JTO Clinical and Research Reports (2023)

Fulltext@MSK | Save

Radiation therapy for de novo anorectal cancer in patients with a history of prostate radiation therapy

Journal Article

Hilal, L.; Wu, A. J.; Reyngold, M.; Cuaron, J. J.; Navilio, J.; Romesser, P. B.; Dreyfuss, A.; Yin, S.; Zhang, Z.; Bai, X.; more...
Frontiers in Oncology (2022)

Fulltext@MSK | Save

Superior post-treatment biopsy outcomes with high dose SBRT compared to high-dose conventionally fractionated IMRT for clinically localized prostate cancer

Meeting Abstract

Zelefsky, M. J.; Kollmeier, M. A.; White, C.; Zhang, Z.; Reuter, V.; Ehdaie, B.; Moore, A.; Samson, F.; Gorovets, D.; Damato, A. L.; more...
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose rate (HDR) vs. low-dose rate (LDR) brachytherapy boost

Meeting Abstract

Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V. S.; Beaudry, J.; Cohen, G.; Damato, A. L.; Zhang, Z.; Zelefsky, M. J.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Focal dose intensification to the dominant intraprostatic lesion (DIL) using an MR-linac adaptive-planning approach for prostate cancer: Dosimetric outcomes and early toxicity

Meeting Abstract

Brennan, V. S.; Burleson, S.; Kostrzewa, C.; Scripes, P. G.; Subashi, E.; Zhang, Z.; Tyagi, N.; Zelefsky, M. J.
International Journal of Radiation Oncology, Biology, Physics (2022)

Fulltext@MSK | Save

Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost

Journal Article

Kollmeier, M. A.; Gorovets, D.; Flynn, J.; McBride, S.; Brennan, V.; Beaudry, J.; Cohen, G.; Damato, A.; Zhang, Z.; Zelefsky, M. J.
Brachytherapy (2022)

Fulltext@MSK | Save

Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity

Journal Article

Teyateeti, A.; Grossman, C.; Kollmeier, M. A.; Fiasconaro, M.; Hopkins, M.; McBride, S.; Gorovets, D.; Shasha, D.; Cohen, G.; Zhang, Z.; more...
BJU International (2022)

Fulltext@MSK | Save

Four-dimensional computed tomography-based correlation of respiratory motion of lung tumors with implanted fiducials and an external surrogate

Journal Article

Willmann, J.; Sidiqi, B.; Wang, C.; Czmielewski, C.; Li, H. J.; Dick-Godfrey, R.; Chawla, M.; Lee, R. P.; Gelb, E.; Wu, A. J.; more...
Advances in Radiation Oncology (2022)

Fulltext@MSK | Save

The rate and risk of secondary pelvic malignancies (SPM) in patients treated with definitive radiation for locally advanced rectal cancer

Meeting Abstract

Tringale, K. R.; Hilal, L.; Wu, A. J. C.; Cercek, A.; Reyngold, M.; Romesser, P. B.; Pappou, E.; Flynn, J.; Zhang, Z.; Navilio, J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save